Evidence map›Paper›PMID 30693189›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Cascade Reaction in Human Live Tissue Allows Clinically Applicable Diagnosis of Breast Cancer Morphology.

Tomonori Tanei, Ambara R Pradipta, Koji Morimoto, Motoko Fujii, Mayumi Arata, Akihiro Ito, Minoru Yoshida, Elena Saigitbatalova, Almira Kurbangalieva, Jun-Ichiro Ikeda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Therapeutic efficacy ofChemical science · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Tomonori TaneiDepartment of Breast and Endocrine Surgery Graduate School of Medicine Osaka University 2-2-E10 Yamadaoka Suita Osaka 565-0871 Japan.
Ambara R PradiptaBiofunctional Synthetic Chemistry Laboratory RIKEN Cluster for Pioneering Research 2-1 Hirosawa Wako Saitama 351-0198 Japan.ORCID https://orcid.org/0000-0002-9056-447X
Koji MorimotoBiofunctional Synthetic Chemistry Laboratory RIKEN Cluster for Pioneering Research 2-1 Hirosawa Wako Saitama 351-0198 Japan.
Motoko FujiiBiofunctional Synthetic Chemistry Laboratory RIKEN Cluster for Pioneering Research 2-1 Hirosawa Wako Saitama 351-0198 Japan.
Mayumi ArataSeed Compounds Exploratory Unit for Drug Discovery Platform RIKEN Center for Sustainable Resource Science 2-1 Hirosawa Wako Saitama 351-0198 Japan.
Akihiro ItoChemical Genomics Research Group RIKEN Center for Sustainable Resource Science 2-1 Hirosawa Wako Saitama 351-0198 Japan.
Minoru YoshidaSeed Compounds Exploratory Unit for Drug Discovery Platform RIKEN Center for Sustainable Resource Science 2-1 Hirosawa Wako Saitama 351-0198 Japan.
Elena SaigitbatalovaBiofunctional Chemistry Laboratory A. Butlerov Institute of Chemistry Kazan Federal University 18 Kremlyovskaya Street Kazan 420008 Russian Federation.
Almira KurbangalievaBiofunctional Chemistry Laboratory A. Butlerov Institute of Chemistry Kazan Federal University 18 Kremlyovskaya Street Kazan 420008 Russian Federation.
Jun-Ichiro IkedaDepartment of Pathology (C3) Graduate School of Medicine Osaka University 2-2 Yamadaoka Suita Osaka 565-0871 Japan.
Eiichi MoriiDepartment of Pathology (C3) Graduate School of Medicine Osaka University 2-2 Yamadaoka Suita Osaka 565-0871 Japan.
Shinzaburo NoguchiDepartment of Breast and Endocrine Surgery Graduate School of Medicine Osaka University 2-2-E10 Yamadaoka Suita Osaka 565-0871 Japan.
Katsunori TanakaBiofunctional Synthetic Chemistry Laboratory RIKEN Cluster for Pioneering Research 2-1 Hirosawa Wako Saitama 351-0198 Japan.ORCID https://orcid.org/0000-0001-6932-4802
Pioneer (United States) · USThe University of Osaka · JPKazan Federal University · RURIKEN Center for Sustainable Resource Science · JPTokyo University of Pharmacy and Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clean operating margins in breast cancer surgery are important for preventing recurrence. However, the current methods for determining margins such as intraoperative frozen section analysis or imprint cytology are not satisfactory since they are time-consuming and cause a burden on the patient and on hospitals with a limited accuracy. A "click-to-sense" probe is developed based on the detection of acrolein, which is a substance released by oxidatively stressed cancer cells and can be visualized under fluorescence microscopy. Using live breast tissues resected from breast cancer patients, it is demonstrated that this method can quickly, selectively, and sensitively differentiate cancer lesion from normal breast gland or benign proliferative lesions. Since acrolein is accumulated in all types of cancers, this method could be used to quickly assess the surgical margins in other types of cancer.

Indexed as

acroleinbreast cancerbreast‐conserving surgeryimagingTAMRA phenyl azide

Identifiers

PMID30693189
PMCPMC6343070
OpenAlexW2903221978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.